Emergent BioSolutions Inc.

2273 Research Boulevard, Suite 400
Rockville, MD 20850
Contact: Kevin Connolly
Telephone: (301) 795-1800
Fax: (301) 795-1899
Email: connollyk@ebsi.com

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent’s product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia.

< < go back to company list